Update: US FDA nod for Aurobindo''s Lisinopril & Hydrochlorothiazide tabs
16 Mar 2006
Aurobindo
Pharma Ltd has announced that the US FDA has approved
its Lisinopril and Hydrochlorothiazide tablets, 10 /
12.5mg, 20 / 12.5mg, and 20 / 25mg.
Lisinopril and Hydrochlorothiazide tablets, 10 / 12.5mg, 20 / 12.5mg, and 20 / 25mg is the generic version of Merck Research Laboratories'' Prinzide Tablets, 10 / 12.5 mg, 20 / 12.5mg, and 20 / 25mg.
The market opportunity for the above product is around $100 million. With this approval Aurbindo''s product basket for the US market has gone to 11.
This combination belongs to the class of medicines called antihypertensives (high blood pressure medicines).
.webp)
